{
  "0": {
    "resourceType": "RegulatedAuthorization",
    "id": "example",
    "identifier": [
      {
        "system": "http://ema.europa.eu/example/marketingAuthorisationNumber",
        "value": "EU/1/11/999/001"
      }
    ],
    "subject": [
      {
        "reference": "MedicinalProductDefinition/example"
      }
    ],
    "type": {
      "coding": [
        {
          "system": "http://ema.europa.eu/example/marketingAuthorisationType",
          "code": "Marketing Authorization"
        }
      ]
    },
    "status": "active",
    "statusDate": "2015-01-14",
    "validityPeriod": {
      "start": "2015-08-16",
      "end": "2020-05-20"
    },
    "holder": {
      "reference": "Organization/example"
    },
    "regulator": {
      "reference": "Organization/ema"
    }
  },
  "1": {
    "resourceType": "RegulatedAuthorization",
    "id": "example2",
    "identifier": [
      {
        "system": "http://fda.gov/nda",
        "value": "NDA123456"
      }
    ],
    "type": {
      "coding": [
        {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
          "code": "HOLDER"
        }
      ]
    },
    "description": "New Drug Application approval for treatment of hypertension",
    "region": [
      {
        "coding": [
          {
            "system": "urn:iso:std:iso:3166",
            "code": "US",
            "display": "United States of America"
          }
        ]
      }
    ],
    "status": "active",
    "statusDate": "2020-03-15",
    "holder": {
      "reference": "Organization/pharma-company"
    },
    "regulator": {
      "reference": "Organization/fda"
    }
  },
  "2": {
    "resourceType": "RegulatedAuthorization",
    "id": "example3",
    "type": {
      "coding": [
        {
          "system": "http://ema.europa.eu/example/regulationType",
          "code": "Clinical Trial Authorization"
        }
      ]
    },
    "status": "active",
    "validityPeriod": {
      "start": "2021-01-01",
      "end": "2024-12-31"
    },
    "indication": {
      "text": "Treatment of Type 2 Diabetes"
    },
    "case": {
      "identifier": {
        "system": "http://example.org/case-numbers",
        "value": "CT-2021-001"
      },
      "type": {
        "coding": [
          {
            "system": "http://example.org/case-types",
            "code": "ClinicalTrialApplication"
          }
        ]
      },
      "status": {
        "coding": [
          {
            "system": "http://example.org/case-status",
            "code": "Approved"
          }
        ]
      },
      "dateDateTime": "2021-01-01T00:00:00Z"
    }
  },
  "3": {
    "resourceType": "RegulatedAuthorization",
    "id": "example4",
    "status": "draft",
    "type": {
      "coding": [
        {
          "system": "http://example.org/authorization-types",
          "code": "Import License"
        }
      ]
    },
    "region": [
      {
        "coding": [
          {
            "system": "urn:iso:std:iso:3166",
            "code": "CA",
            "display": "Canada"
          }
        ]
      }
    ],
    "basis": [
      {
        "coding": [
          {
            "system": "http://example.org/basis",
            "code": "Reciprocal",
            "display": "Reciprocal recognition"
          }
        ]
      }
    ],
    "holder": {
      "reference": "Organization/importer"
    }
  }
}
